Search

everythinglearnresearchcommunity

for

Search:↓

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Pediatric systemic lupus erythematosus is a severe autoimmune disease in children requiring early diagnosis and comprehensive management.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.

Renal histology is crucial for diagnosing simultaneous SLE and IgG4RD.

New treatments for lupus show promise, but more research is needed, especially for children.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

SLE patients experience two patterns of non-inflammatory symptoms: intermittent and persistent.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Adding a second method to PROTACs could improve cancer treatment.